{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/fungal-nail-infection/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"eec0a81e-c0c0-5f9d-951e-f19c41cfafaf","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field c8efb1ae-d144-4014-bbc6-b4d41522247a --><h2>How should I assess suspected fungal nail infection?</h2><!-- end field c8efb1ae-d144-4014-bbc6-b4d41522247a -->","summary":"","htmlStringContent":"<!-- begin item 2a3ef8d7-1256-48c4-aa47-ccc4556303ec --><!-- begin field 3080ead3-bde7-44df-b81e-51f0e63b3ddc --><p><strong>If fungal nail infection is</strong><strong> </strong><strong><a class=\"topic-reference internal-reference\" href=\"/topics/fungal-nail-infection/diagnosis/diagnosis/\">suspected</a></strong><strong> </strong><strong>on the basis of clinical features: </strong></p><ul><li><strong>Ask the person about:</strong><ul><li>Symptoms such as pain and discomfort.</li><li>Any impact on psychosocial functioning and quality of life, such as difficulty wearing footwear and walking.</li><li>Any co-morbidities or <a class=\"topic-reference internal-reference\" href=\"/topics/fungal-nail-infection/background-information/risk-factors/\">risk factors</a> for infection.</li><li>Any family or household members affected.</li></ul></li><li><strong>Examine the person to assess:</strong><ul><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/fungal-nail-infection/diagnosis/diagnosis/\">type</a> of onychomycosis, if possible.</li><li>For any associated fungal infection at other sites, or paronychia, which may need treatment. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-body-groin/\">Fungal skin infection - body and groin</a>, <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-foot/\">Fungal skin infection - foot</a>, <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-scalp/\">Fungal skin infection - scalp</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/paronychia-acute/\">Paronychia - acute</a> for more information.</li></ul></li><li><strong>Arrange for </strong><a class=\"topic-reference internal-reference\" href=\"/topics/fungal-nail-infection/diagnosis/assessment/#taking-nail-samples\">nail clippings and/or scrapings</a> for fungal microscopy and culture to confirm the diagnosis and underlying <a class=\"topic-reference internal-reference\" href=\"/topics/fungal-nail-infection/background-information/causes/\">cause</a>, if the person wishes to consider <a class=\"topic-reference internal-reference\" href=\"/topics/fungal-nail-infection/management/\">management</a> with antifungal treatments.<ul><li>Interpret the results as positive if:<ul><li>For dermatophytes, <em>either </em>microscopy or culture is positive.</li><li>For <em>Candida</em> species, <em>both </em>microscopy and culture are positive.</li><li>For non-dermatophytes, <em>both </em>microscopy and culture are positive on at <em>least two samples </em>taken at different times.</li></ul></li><li>Interpret the results with caution, as false-negative rates for culture may be as high as 30%.<ul><li>Advise the person a negative test result cannot definitively exclude fungal nail infection.</li><li>Arrange for repeat samples to be taken if the result is negative and there is a high clinical suspicion of fungal nail infection.</li></ul></li></ul></li></ul><!-- end field 3080ead3-bde7-44df-b81e-51f0e63b3ddc --><!-- end item 2a3ef8d7-1256-48c4-aa47-ccc4556303ec -->","topic":{"id":"1303927b-7e0c-517d-85e9-841c9ac02151","topicId":"d2c6135f-fef1-4a56-80dc-161c93380c7d","topicName":"Fungal nail infection","slug":"fungal-nail-infection","lastRevised":"Last revised in March 2018","chapters":[{"id":"bc563964-f1b0-559d-9f21-380162710ddf","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"dd347390-fb63-5e80-9fab-bd3cc4704341","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0cdd100c-c9d0-5685-980c-52f246d1100e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"886d32db-68df-5055-b459-55404c1f011e","slug":"changes","fullItemName":"Changes"},{"id":"c1cacd2b-dba0-5341-a274-66fd882b2036","slug":"update","fullItemName":"Update"}]},{"id":"9f0a65a3-9309-5a00-a9fa-bda2fb7a49c4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1121797b-5555-5e24-a9ae-aabc657725dd","slug":"goals","fullItemName":"Goals"},{"id":"aa660497-e222-5e9d-b282-3069500c380f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"49df22af-d1aa-56cd-b2dc-30e6ecc84ca8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a79a5fd4-4f6a-5d37-8714-e4bd3bea76b0","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6db25a8b-db82-5b72-bade-fa216c349fd8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2515b15e-47ac-5e93-acaf-588daa2e06f0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d257da5b-218f-50fc-96b1-55ec4b44f5cd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"7ccd879d-9979-5f0b-b655-8da37ca04149","slug":"definition","fullItemName":"Definition"},{"id":"20d20421-b2ba-513f-87b5-3fad4f731aa5","slug":"causes","fullItemName":"Causes"},{"id":"3142330a-0287-5835-8a69-857972828fb2","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"29b083db-9488-5407-92df-43f4952d8df3","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d7dd4e0b-6a97-5db7-bfa3-aa690c7974af","slug":"complications","fullItemName":"Complications"},{"id":"3a29be3f-ea9f-56a3-b8d7-78341665856e","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4346dd42-e5eb-550e-a004-7c8e7103a196","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b6a7486c-a6d8-5d8b-918c-8610bf76e212","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"eec0a81e-c0c0-5f9d-951e-f19c41cfafaf","slug":"assessment","fullItemName":"Assessment"},{"id":"d84aa70d-b236-5783-9eeb-e1181b1311f8","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"12363e3a-9d3f-54c7-8f68-1145b8f312b3","fullItemName":"Management","slug":"management","subChapters":[{"id":"36068044-ec28-5f59-b737-dd89aa53cca5","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"94da5137-b65a-5fa1-a933-bbcaa1a5c10b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"6780cd52-ecfd-5eba-8c7e-66bc71b64ed2","slug":"topical-amorolfine","fullItemName":"Topical amorolfine"},{"id":"7009ace0-8da0-5da4-917e-8900ae3cc390","slug":"oral-terbinafine","fullItemName":"Oral terbinafine"},{"id":"5d413d25-a998-5ee4-ad9d-be6306400282","slug":"oral-itraconazole","fullItemName":"Oral itraconazole"}]},{"id":"0b102b3a-ebce-5c6e-9670-3610defc871d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bc0bd4bc-1b10-52dc-b942-cd4682774d01","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"dc202e28-37b1-5789-a14a-b5a0850d8cf8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"49993e8c-ae7a-5891-bf43-21a6406ce1b5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b6aa45b7-d833-599f-8bcc-4d08c6c264bb","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2805cbb7-09b5-5875-a0c1-c501223c6ab3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"595745a2-d654-5e3b-850e-eac6532bd5db","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74af204e-7571-5d05-963f-0c0614335fbf","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4346dd42-e5eb-550e-a004-7c8e7103a196","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"608451ed-c8a9-510d-bbee-f7394c8cd802","slug":"taking-nail-samples","fullItemName":"Taking nail samples","depth":3,"htmlHeader":"<!-- begin field 4d688da0-06b4-46ea-a840-f83f139ec318 --><h3>Taking nail samples</h3><!-- end field 4d688da0-06b4-46ea-a840-f83f139ec318 -->","summary":null,"htmlStringContent":"<!-- begin item 09041b3e-8012-43ca-aca6-cd257663d825 --><!-- begin field fc9b979a-2ee8-416b-9db7-02f3c142651c --><ul><li><strong>When taking samples of the abnormal nail (nail clippings), and any debris between the nail and nail bed (nail scrapings):</strong><ul><li>Wipe off any treatment creams, lotions, or powders with 70% alcohol before sampling, to prevent contamination.</li><li>If superficial infection of the nail is suspected, use a scalpel blade to obtain scrapings of the surface of the nail.</li><li>If deeper infection of the nail is suspected:<ul><li>When clipping the diseased nail, use sterile nail clippers or chiropody scissors to include the full thickness of the nail and extend as far back from the nail tip as possible (viable fungi are most likely to be found in the most proximal part of diseased nail; distal nail samples should be avoided as contamination is common).</li><li>Include scrapings of debris from the area between the nail and nail bed using a sterile scalpel blade.</li></ul></li><li>Collect the samples into folded dark paper squares, secure with a paper clip, and place in a plastic sample bag. Alternatively, commercially available packs are available. Label the sample clearly.</li><li>Keep the samples at room temperature and do <em>not </em>refrigerate (dermatophytes are inhibited at low temperatures, and humidity facilitates the growth of contaminants).</li><li>Inform the person microscopy results (to identify hyphae, pseudohyphae, or spores) should be available within 1–2 days; culture results (to identify the causative organism) within 2–3 weeks.</li><li>Be aware that testing for antifungal susceptibilities is not required.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Westerberg, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Ameen, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Eisman, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">PHE, 2017</a>] </p><!-- end field fc9b979a-2ee8-416b-9db7-02f3c142651c --><!-- end item 09041b3e-8012-43ca-aca6-cd257663d825 -->","subChapters":[]},{"id":"f6f41fe5-cc48-5671-a2f1-81cfa2692821","slug":"basis-for-recommendation-373","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 80be1527-f2ab-4581-9288-5e791675aaa8 --><h3>Basis for recommendation</h3><!-- end field 80be1527-f2ab-4581-9288-5e791675aaa8 -->","summary":null,"htmlStringContent":"<!-- begin item 3737f9f1-6c9c-44e4-b4a0-c2a322610f42 --><!-- begin field 203cf2f2-1439-45f3-88d2-212b498a9c35 --><p>The recommendations on assessment are based on expert opinion in the British Association of Dermatologists' (BAD) <em>Guidelines for the management of onychomycosis 2014</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Ameen, 2014</a>], the Public Health England (PHE) publication <em>Fungal skin and nail infections: Diagnosis and laboratory investigation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">PHE, 2017</a>], and expert opinion in review articles on fungal nail infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Eisman, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Tosti, 2016</a>].</p><ul><li>Distal nail infection with <em>Candida </em>yeasts is uncommon and the majority of people affected also have Raynaud's phenomenon or some other form of vascular insufficiency [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Ameen, 2014</a>].</li><li>In children with fungal nail infection, parents and siblings should be examined to exclude active infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Eisman, 2014</a>].</li><li>The recommendation to assess for fungal infection at other sites is based on the fact that toenail infection is often associated with tinea pedis, and fingernail infection is often associated with tinea corporis or tinea capitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Eisman, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Tosti, 2016</a>].</li></ul><h4>Advice on nail sampling and interpretation of results</h4><ul><li>The recommendation to perform nail sampling on any person considering antifungal treatment is extrapolated from expert opinion in the BAD publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Ameen, 2014</a>] and the PHE publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">PHE, 2017</a>]. The detailed information on nail sampling is based on the fact that good nail specimens give the maximal chance of identifying the causative organism, and therefore targeting treatment appropriately [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Ameen, 2014</a>]. <ul><li>Fungal culture is important as it distinguishes dermatophyte from non-dermatophyte infection which present similarly, as these two organisms may need different treatment approaches [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Ameen, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">PHE, 2017</a>].</li><li>The information on the false-negative rates for mycology culture is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Eisman, 2014</a>]. The PHE publication notes that only 45% of mycological samples received are positive for fungal infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">PHE, 2017</a>].</li><li>The recommendation to arrange repeat fungal microscopy and culture to confirm the presence of non-dermatophyte infection is extrapolated from the PHE publication, which states that diagnosis requires positive microscopy and culture, ideally on repeated occasions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">PHE, 2017</a>]. This is supported by expert opinion in the BAD guidelines, which note that non-dermatophyte organisms are often transient contaminants or commensals of uncertain clinical significance, and microscopy of nail samples is often negative. Consistent isolation of these organisms on repeat sampling suggests they are a true pathogen [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Ameen, 2014</a>].</li><li>The recommendation to repeat nail sampling if the result is negative and clinical suspicion of fungal nail infection is high is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Eisman, 2014</a>].</li><li>The recommendation that antifungal susceptibility testing is not needed is based on the fact that antifungal resistance is rare, and there is no known correlation between antifungal susceptibilities and outcome [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">PHE, 2017</a>].</li></ul></li></ul><!-- end field 203cf2f2-1439-45f3-88d2-212b498a9c35 --><!-- end item 3737f9f1-6c9c-44e4-b4a0-c2a322610f42 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}